Patents by Inventor Irina Shalaurova

Irina Shalaurova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR Spectroscopy
    Publication number: 20230024795
    Abstract: Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.
    Type: Application
    Filed: September 19, 2022
    Publication date: January 26, 2023
    Inventors: James D. Otvos, Irina Shalaurova, Alan Remaley, Maureen Sampson, Lita Freeman
  • Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy
    Patent number: 11467171
    Abstract: Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: October 11, 2022
    Inventors: James D. Otvos, Irina Shalaurova, Alan Remaley, Maureen Sampson, Lita Freeman
  • METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z
    Publication number: 20220011388
    Abstract: Described herein are methods for the determination of patient mortality from alcoholic hepatitis in biosamples by NMR spectroscopy and more specifically for the determination of a Z index score based on lipoprotein constituent LP-Z in blood plasma and serum.
    Type: Application
    Filed: November 7, 2019
    Publication date: January 13, 2022
    Inventors: Zhenghui Gordon Jiang, James D. Otvos, Irina Shalaurova, Elias J. Jeyarajah, Margery A. Connelly, Michael Curry, Nezam Afdhal, Yury Popov, Maria Perez-Matos
  • Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR Spectroscopy
    Publication number: 20190145990
    Abstract: Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.
    Type: Application
    Filed: November 13, 2018
    Publication date: May 16, 2019
    Inventors: James D. Otvos, Irina Shalaurova, Alan Remaley, Maureen Sampson, Lita Freeman